- Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024
- Singular Genomics Showcases New G4X™ Spatial Sequencer at AGBT and Announces Significant Advances in Throughput, Quality, and Usability for G4® Sequencing Platform
- Singular Genomics Unveils G4X™ Spatial Sequencer, Transforming the Landscape of In Situ Multiomic Analysis
- Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue
- Singular Genomics Reports Recent Highlights and Third Quarter 2023 Financial Results
- Singular Genomics to Report Third Quarter 2023 Financial Results on November 14, 2023
- Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase
- Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial Results
- Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
More ▼
Key statistics
On Friday, Singular Genomics Systems Inc (OMIC:NAQ) closed at 0.4042, 30.35% above the 52 week low of 0.3101 set on Nov 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.41 |
---|---|
High | 0.41 |
Low | 0.3762 |
Bid | 0.376 |
Offer | 0.41 |
Previous close | 0.4006 |
Average volume | 109.93k |
---|---|
Shares outstanding | 73.93m |
Free float | 60.31m |
P/E (TTM) | -- |
Market cap | 29.88m USD |
EPS (TTM) | -1.30 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼